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The increased prevalence of obesity and related comorbidities is a major public health problem. While genetic
factors undoubtedly play a role in determining individual susceptibility to weight gain and obesity, the identified
genetic variants only explain part of the variation. This has led to growing interest in understanding the potential
role of epigenetics as a mediator of gene-environment interactions underlying the development of obesity and its
associated comorbidities. Initial evidence in support of a role of epigenetics in obesity and type 2 diabetes mellitus
(T2DM) was mainly provided by animal studies, which reported epigenetic changes in key metabolically important
tissues following high-fat feeding and epigenetic differences between lean and obese animals and by human
studies which showed epigenetic changes in obesity and T2DM candidate genes in obese/diabetic individuals.
More recently, advances in epigenetic methodologies and the reduced cost of epigenome-wide association studies
(EWAS) have led to a rapid expansion of studies in human populations. These studies have also reported epigenetic
differences between obese/T2DM adults and healthy controls and epigenetic changes in association with nutritional,
weight loss, and exercise interventions. There is also increasing evidence from both human and animal studies that
the relationship between perinatal nutritional exposures and later risk of obesity and T2DM may be mediated by
epigenetic changes in the offspring. The aim of this review is to summarize the most recent developments in this
rapidly moving field, with a particular focus on human EWAS and studies investigating the impact of nutritional and
lifestyle factors (both pre- and postnatal) on the epigenome and their relationship to metabolic health outcomes.
The difficulties in distinguishing consequence from causality in these studies and the critical role of animal models
for testing causal relationships and providing insight into underlying mechanisms are also addressed. In summary,
the area of epigenetics and metabolic health has seen rapid developments in a short space of time. While the
outcomes to date are promising, studies are ongoing, and the next decade promises to be a time of productive
research into the complex interactions between the genome, epigenome, and environment as they relate to
metabolic disease.
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Obesity is a complex, multifactorial disease, and better
understanding of the mechanisms underlying the inter-
actions between lifestyle, environment, and genetics is
critical for developing effective strategies for preven-
tion and treatment [1].
In a society where energy-dense food is plentiful
and the need for physical activity is low, there is a
wide variation in individuals’ susceptibility to develop* Correspondence: Peter.Molloy@csiro.au
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the role of heredity in this variation are in the range
of 40–70 %, and while large genome-wide association
studies (GWAS) have identified a number of genetic
loci associated with obesity risk, the ~100 most com-
mon genetic variants only account for a few percent
of variance in obesity [2, 3]. Genome-wide estimates are
higher, accounting for ~20 % of the variation [3]; however,
a large portion of the heritability remains unexplained.
Recently, attention has turned to investigating the role
of epigenetic changes in the etiology of obesity. It has
been argued that the epigenome may represent the mech-
anistic link between genetic variants and environmentalarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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the “missing heritability.” The first human epigenetic
studies were small and only investigated a limited number
of loci. While this generally resulted in poor reproducibil-
ity, some of these early findings, for instance the relation-
ship between PGC1A methylation and type 2 diabetes
mellitus (T2DM) [4] and others as discussed in van
Dijk et al. [5], have been replicated in later studies.
Recent advances and increased affordability of high-
throughput technologies now allow for large-scale
epigenome-wide association studies (EWAS) and integra-
tion of different layers of genomic information to explore
the complex interactions between the genotype, epige-
nome, transcriptome, and the environment [6–9]. These
studies are still in their infancy, but the results thus
far have shown promise in helping to explain the vari-
ation in obesity susceptibility.
There is increasing evidence that obesity has develop-
mental origins, as exposure to a suboptimal nutrient
supply before birth or in early infancy is associated with
an increased risk of obesity and metabolic disease in
later life [10–13]. Initially, animal studies demonstrated
that a range of early life nutritional exposures, especially
those experienced early in gestation, could induce epi-
genetic changes in key metabolic tissues of the offspring
that persisted after birth and result in permanent alter-
ations in gene function [13–17]. Evidence is emerging
to support the existence of the same mechanism in
humans. This has led to a search for epigenetic marks
present early in life that predict later risk of metabolic
disease, and studies to determine whether epigenetic
programming of metabolic disease could be prevented
or reversed in later life.
This review provides an update of our previous sys-
tematic review of studies on epigenetics and obesity in
humans [5]. Our previous review showcased the promis-
ing outcomes of initial studies, including the first poten-
tial epigenetic marks for obesity that could be detected
at birth (e.g., RXRA) [18]. However, it also highlighted
the limited reproducibility of the findings and the lack
of larger scale longitudinal investigations. The current
review focuses on recent developments in this rapidly
moving field and, in particular, on human EWAS and
studies investigating the impact of (pre- and postnatal)
nutritional and lifestyle factors on the epigenome and
the emerging role of epigenetics in the pathology of
obesity. We also address the difficulties in identifying
causality in these studies and the importance of animal
models in providing insight into mechanisms.
Review
Epigenetic changes in animal models of obesity
Animal models provide unique opportunities for highly
controlled studies that provide mechanistic insight intothe role of specific epigenetic marks, both as indicators
of current metabolic status and as predictors of the fu-
ture risk of obesity and metabolic disease. A particularly
important aspect of animal studies is that they allow for
the assessment of epigenetic changes within target tis-
sues, including the liver and hypothalamus, which is
much more difficult in humans. Moreover, the ability to
harvest large quantities of fresh tissue makes it possible
to assess multiple chromatin marks as well as DNA
methylation. Some of these epigenetic modifications
either alone or in combination may be responsive to
environmental programming. In animal models, it is also
possible to study multiple generations of offspring and
thus enable differentiation between transgenerational
and intergenerational transmission of obesity risk medi-
ated by epigenetic memory of parental nutritional status,
which cannot be easily distinguished in human studies.
We use the former term for meiotic transmission of
risk in the absence of continued exposure while the
latter primarily entails direct transmission of risk through
metabolic reprogramming of the fetus or gametes.
Animal studies have played a critical role in our
current understanding of the role of epigenetics in the
developmental origins of obesity and T2DM. Both in-
creased and decreased maternal nutrition during preg-
nancy have been associated with increased fat deposition
in offspring of most mammalian species studied to date
(reviewed in [11, 13–15, 19]). Maternal nutrition during
pregnancy not only has potential for direct effects on
the fetus, it also may directly impact the developing
oocytes of female fetuses and primordial germ cells of
male fetuses and therefore could impact both the off-
spring and grand-offspring. Hence, multigenerational
data are usually required to differentiate between mater-
nal intergenerational and transgenerational transmission
mechanisms.
Table 1 summarizes a variety of animal models that
have been used to provide evidence of metabolic and
epigenetic changes in offspring associated with the par-
ental plane of nutrition. It also contains information
pertaining to studies identifying altered epigenetic marks
in adult individuals who undergo direct nutritional chal-
lenges. The table is structured by suggested risk trans-
mission type.
(i) Epigenetic changes in offspring associated with
maternal nutrition during gestation
Maternal nutritional supplementation, undernutrition,
and overnutrition during pregnancy can alter fat depos-
ition and energy homeostasis in offspring [11, 13–15, 19].
Associated with these effects in the offspring are changes
in DNA methylation, histone post-translational modi-
fications, and gene expression for several target genes,
Table 1 Evidence for a role of epigenetics in animal models of obesity separated by transmission type
Transmission type Species Experimental model Phenotype affected Epigenetic changes Ref.
Intergenerational
maternal effect
Sheep Periconceptional undernutrition in normal
and overweight ewes using artificial
insemination and embryo transfer
Fat deposition and adrenal changes in
offspring
Decreased expression of IGF2 and decreased DNA
methylation of a proximal imprinting control region;
changes in adrenal IGF2 DNA methylation;




Sheep Maternal undernutrition prior to conception
and during early gestation
Programming of obesity Altered offspring histone methylation and acetylation




Sheep Different maternal dietary energy sources
during that last half of gestation
Late gestation fetal gene expression
and DNA methylation from a variety
of tissues
Changes in late gestation fetal DNA methylation of





Pig Methylating micronutrient supplementation
during gestation—impacts on F2
Back fat percentage, adipose tissue,
and fat thickness at 10th rib, croup,
and shoulder in F2
Differentially expressed metabolic genes in F2 liver




Mouse Maternal low-protein diet during gestation
and maternal diet restriction during gestation
Body weight, food intake, and adiposity Altered germline DNA methylation of F1 adult males
in a locus specific manner; changed expression and
DNA methylation of LXRA in liver; demethylation of




Mouse Maternal high-fat diet during gestation;
maternal obesity model; maternal high-fat
diet using a Glut4+/− genetic background;
maternal diet-induced obesity
Offspring chromatin organization;
metabolic syndrome in offspring
unmasked by exposure to western
diet; glucose intolerance, insulin
resistance, hepatic steatosis; obesity;
exacerbated metabolic syndrome in
offspring; insulin levels, insulin resistance
in adipose tissue
Changes in offspring hepatic histone marks H3K14ac
and H3K9me3; changes in offspring hepatic gene
expression and widespread subtle changes in
cytosine methylation; DNA methylation change in
PEG3 in spermatozoa of offspring; cell autonomous
transmission of altered insulin signaling. Reduced
IRS1 expression associated with elevated miR126
[21, 24, 28, 93]
Intergenerational
maternal effect
Rat Maternal diet restriction during gestation;
suboptimal diet during early gestation
Catch up growth, obesity, and liver
weight; T2D
Change in offspring liver IGF1 expression and IGF1
H3K4 methylation; decreased PPARA expression and
increased DNA methylation in the PPARA promoter
in liver; dhange in offspring growth hormone and
PPARA expression and DNA methylation in liver;
chromatin changes affecting enhancer/promoter
interactions at HNF4A promoter in pancreatic islets
from offspring
[17, 25, 29, 30]
Intergenerational
maternal effect
Rat Maternal overfeeding model during
preconception and gestation
Adipogenesis, gene expression and
reduced representation DNA methylation
in offspring
Changes in gene expression and proximal DNA





Macaque Maternal high-fat diet during gestation Altered expression of Npas2 Changes in offspring fetal liver chromatin mark




Drosophila Paternal overnutrition Obesity in offspring Chromatin (H3K9me3 and H3K27me3)-dependent
reprogramming of offspring metabolic genes; a
similar system may regulate obesity susceptibility

















Table 1 Evidence for a role of epigenetics in animal models of obesity separated by transmission type (Continued)
Intergenerational
paternal effect
Mouse Intrauterine growth restriction F1 offspring become obese and
glucose intolerant with aging
F1 males show change in methylation of LXRA in




Mouse Paternal prediabetes F1 has increased susceptibility to
diabetes
F1 show changes in pancreatic gene expression
and DNA methylation linked to insulin signaling.






Mouse Avy mouse—change in coat color and adult
onset obesity through maternal transmission
to the next generation; modulation by methyl
donors and genistein during gestation.
Coat color and adult onset obesity
in offspring
DNA methylation of a retrotransposon promoter
adjacent to the agouti gene; evidence for germ
line transmission of methylation status
[38–41, 94]
Effect resulting from
direct exposure of adult
Mouse High-fat diet Weight, fasting glucose, glucose,
and insulin tolerance tests; obesity
Differential DNA methylation at numerous sites
in adipose tissue; changes in DNA methylation
of metabolism-related genes in liver and oocytes
[43, 95]
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insulin signaling [16, 17, 20–30]. The diversity of ani-
mal models used in these studies and the common
metabolic pathways impacted suggest an evolutionar-
ily conserved adaptive response mediated by epigenetic
modification. However, few of the specific identified
genes and epigenetic changes have been cross-validated
in related studies, and large-scale genome-wide investiga-
tions have typically not been applied. A major hindrance
to comparison of these studies is the different develop-
mental windows subjected to nutritional challenge, which
may cause considerably different outcomes. Proof that
the epigenetic changes are causal rather than being asso-
ciated with offspring phenotypic changes is also required.
This will necessitate the identification of a parental nutri-
tionally induced epigenetic “memory” response that pre-
cedes development of the altered phenotype in offspring.
(ii)Effects of paternal nutrition on offspring epigenetic
marks
Emerging studies have demonstrated that paternal
plane of nutrition can impact offspring fat deposition
and epigenetic marks [31–34]. One recent investiga-
tion using mice has demonstrated that paternal predi-
abetes leads to increased susceptibility to diabetes in
F1 offspring with associated changes in pancreatic gene
expression and DNA methylation linked to insulin signal-
ing [35]. Importantly, there was an overlap of these
epigenetic changes in pancreatic islets and sperm sug-
gesting germ line inheritance. However, most of these
studies, although intriguing in their implications, are
limited in the genomic scale of investigation and fre-
quently show weak and somewhat transient epigenetic
alterations associated with mild metabolic phenotypes in
offspring.
(iii)Potential transgenerational epigenetic changes
promoting fat deposition in offspring
Stable transmission of epigenetic information across
multiple generations is well described in plant systems
and C. elegans, but its significance in mammals is still
much debated [36, 37]. An epigenetic basis for grand-
parental transmission of phenotypes in response to diet-
ary exposures has been well established, including in
livestock species [31]. The most influential studies dem-
onstrating effects of epigenetic transmission impacting
offspring phenotype have used the example of the viable
yellow agouti (Avy) mouse [38]. In this mouse, an inser-
tion of a retrotransposon upstream of the agouti gene
causes its constitutive expression and consequent yellow
coat color and adult onset obesity. Maternal transmis-
sion through the germ line results in DNA methylationmediated silencing of agouti expression resulting in
wild-type coat color and lean phenotype of the offspring
[39, 40]. Importantly, subsequent studies in these mice
demonstrated that maternal exposure to methyl donors
causes a shift in coat color [41]. One study has reported
transmission of a phenotype to the F3 generation and
alterations in expression of large number of genes in
response to protein restriction in F0 [42]; however, alter-
ations in expression were highly variable and a direct
link to epigenetic changes was not identified in this
system.
(iv)Direct exposure of individuals to excess nutrition in
postnatal life
While many studies have identified diet-associated
epigenetic changes in animal models using candidate
site-specific regions, there have been few genome-wide
analyses undertaken. A recent study focussed on deter-
mining the direct epigenetic impact of high-fat diets/
diet-induced obesity in adult mice using genome-wide
gene expression and DNA methylation analyses [43].
This study identified 232 differentially methylated re-
gions (DMRs) in adipocytes from control and high-fat
fed mice. Importantly, the corresponding human regions
for the murine DMRs were also differentially methylated
in adipose tissue from a population of obese and lean
humans, thereby highlighting the remarkable evolution-
ary conservation of these regions. This result emphasizes
the likely importance of the identified DMRs in regulat-
ing energy homeostasis in mammals.
Human studies
Drawing on the evidence from animal studies and with
the increasing availability of affordable tools for genome-
wide analysis, there has been a rapid expansion of epi-
genome studies in humans. These studies have mostly
focused on the identification of site-specific differences
in DNA methylation that are associated with metabolic
phenotypes.
A key question is the extent to which epigenetic
modifications contribute to the development of the
metabolic phenotype, rather than simply being a con-
sequence of it (Fig. 1). Epigenetic programming could
contribute to obesity development, as well as playing a
role in consequent risk of cardiovascular and meta-
bolic problems. In human studies, it is difficult to prove
causality [44], but inferences can be made from a number
of lines of evidence:
(i) Genetic association studies. Genetic polymorphisms
that are associated with an increased risk of
developing particular conditions are a priori linked
to the causative genes. The presence of differential
Fig. 1 Epigenetic changes as a cause or consequence of obesity and related comorbidities. An epigenetic change is indicated as a star on the DNA
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relevance of these epigenetic changes in controlling
expression of the proximal gene(s). There are
strong cis-acting genetic effects underpinning much
epigenetic variation [7, 45], and in population-based
studies, methods that use genetic surrogates to infer
a causal or mediating role of epigenome differences
have been applied [7, 46–48]. The use of familial
genetic information can also lead to the
identification of potentially causative candidate
regions showing phenotype-related differential
methylation [49].
(ii)Timing of epigenetic changes. The presence of an
epigenetic mark prior to development of a
phenotype is an essential feature associated with
causality. Conversely, the presence of a mark in
association with obesity, but not before its
development, can be used to exclude causality
but would not exclude a possible role in subsequent
obesity-related pathology.
(iii)Plausible inference of mechanism. This refers to
epigenetic changes that are associated with altered
expression of genes with an established role in
regulating the phenotype of interest. One such
example is the association of methylation at two
CpG sites at the CPT1A gene with circulating
triglyceride levels [50]. CPT1A encodes carnitine
palmitoyltransferase 1A, an enzyme with a central
role in fatty acid metabolism, and this is strongly
indicative that differential methylation of this gene
may be causally related to the alterations in plasma
triglyceride concentrations.Epigenome-wide association studies: identifying epigenetic
biomarkers of metabolic health
A number of recent investigations have focused on ex-
ploring associations between obesity/metabolic diseasesand DNA methylation across the genome (Table 2). The
largest published EWAS so far, including a total of
5465 individuals, identified 37 methylation sites in blood
that were associated with body mass index (BMI), includ-
ing sites in CPT1A, ABCG1, and SREBF1 [51]. Another
large-scale study showed consistent associations between
BMI and methylation in HIF3A in whole blood and
adipose tissue [52], a finding which was also partially
replicated in other studies [9, 51]. Other recently re-
ported associations between obesity-related measures
and DNA methylation include (i) DNA methylation
differences between lean and obese individuals in LY86
in blood leukocytes [53]; (ii) associations between PGC1A
promoter methylation in whole blood of children and
adiposity 5 years later [54]; (iii) associations between
waist-hip ratio and ADRB3 methylation in blood [55];
and (iv) associations between BMI, body fat distribution
measures, and multiple DNA methylation sites in adipose
tissue [9, 56]. EWAS have also shown associations between
DNA methylation sites and blood lipids [55, 57–59],
serum metabolites [60], insulin resistance [9, 61], and
T2DM [48, 62, 63] (Table 2).
From these studies, altered methylation of PGC1A,
HIF3A, ABCG1, and CPT1A and the previously described
RXRA [18] have emerged as biomarkers associated with,
or perhaps predictive of, metabolic health that are also
plausible candidates for a role in development of meta-
bolic disease.Interaction between genotype and the epigenome
Epigenetic variation is highly influenced by the under-
lying genetic variation, with genotype estimated to ex-
plain ~20–40 % of the variation [6, 8]. Recently, a
number of studies have begun to integrate methylome
and genotype data to identify methylation quantitative
trait loci (meQTL) associated with disease phenotypes.
For instance, in adipose tissue, an meQTL overlapping
Table 2 Representative human studies showing evidence for a role of epigenetics in obesity and related comorbidities
Phenotype Association with epigenetic marks or changes in epigenetic marksa Includes validationb Ref.
Cross-sectional studies
BMI, WC Methylation in 37 CpGs associated with BMI and 1 probe with WC in blood (n = 5465);
of those 16 CpGs (e.g., CpGs in CPT1A, ABCG1, and SREBPF1) were also associated with
BMI in subcutaneous adipose tissue (n = 648)
Yes, 3 other cohorts [51]
BMI DNA methylation of 4979 CpGs (e.g., in FTO, TCF7L2, FASN, PGC1A, CCRL2) in subcutaneou
adipose tissue (n = 190). Several BMI-related methylation sites were also associated with
age (e.g., ELOVL2), and with gene expression levels
Yes, 2nd cohort [9]
BMI HIF3A methylation 3 CpGs in whole blood (n = 2587) and subcutaneous adipose tissue
(n = 635), not in skin (n = 395)
Yes, 3 other cohorts [52]
Obesity LY86 methylation 1 CpG in blood leukocytes adolescents and adults (n = 1534) Yes, 4 other cohorts [53]
Obesity 249 DMRs in subcutaneous adipose tissue (n = 21), methylation in all these 249 regions
also changed with high-fat feeding in mice and includes regions overlapping T2DM loci
such as in TCF7L2
No, only in mice [43]
WHR, blood pressure LDL cholesterol Association between WHR and ADRB3 methylation in whole blood and between blood
pressure and ADRB3 methylation in visceral adipose tissue of obese (n = 25). Association
between ADRB3 methylation and LDL cholesterol in whole blood of men with familial
hypercholesterolemia (n = 41)
Not validated in 2nd cohort [55]
BMI ADCY3 meQTL in subcutaneous adipose tissue from twins (n = 648) Yes, technical [8]
BMI Methylation differences at 1236 CpGs in leukocytes of monozygotic twins discordant for
BMI and liver fat (n = 13)
Yes, technical [96]
Adiposity phenotypes Methylation in 101 genes in subcutaneous adipose tissue (n = 106) including AOC3, SOD3
DOCK9, AQP7, ANGPT4, ANGPT2, TIMP4, ADAMST4, HOXA3, and LIPE, not found in blood
leukocytes same individuals
No validation performed [56]
TG, VLDL CPT1A methylation 1 CpG in CD4+T cells (n = 991) and leukocytes (n = 1261) Yes, technical and 2nd cohort [57]
VLDL and LDL CPT1A methylation 2 CpGs in CD4+T cells (n = 994) Yes, in the same cohort [58]
Cholesterol and TG Methylation in 9 CpGs, including in ABCG1, CPT1A and SREBF1, in whole blood (n = 2747)
5 of these CpGs also showed associations in subcutaneous adipose tissue (n = 634)
Yes, 2 other cohorts [59]
Insulin and HOMA-IR ABCG1 1 CpG in CD4+T cells (n = 837) Yes, in the same cohort [61]
HbA1C DNA methylation of 711 CpGs in subcutaneous adipose tissue (n = 96 males). Not validat
in female cohort (n = 94) but 30 CpGs validated in T2DM case-control cohort
Yes, validated in 1 of 2 cohorts [9]
T2DM MALT1 methylation whole blood (n = 27 twins + n = 263 individuals) and other less signif nt
DMRs (FDR < 0.1) overlapping T2DM GWAS loci
Yes, other cohort [48]
T2DM Methylation in 1649 CpG sites, some overlapping T2DM, and obesity GWAS loci such as
TCF7L2, FTO, and KCNQ1 in pancreatic islets (n = 49)
Yes, technical [62]
T2DM No differentially methylated sites (after FDR correction) in T2DM discordant monozygotic
twins (n = 14 pairs). Differential methylation at 15,627 CpGs, including in T2DM GWAS loc
PPARG, KCNQ1, TCF7L2, and IRS1 in subcutaneous adipose tissue (n = 56). 1410 of these
CpGs were also differentially methylated (P < 0.05) in the T2DM discordant twins
















Table 2 Representative human studies showing evidence for a role of epigenetics in obesity and related comorbidities (Continued)
Longitudinal studies
Adiposity measured annually age 9–14 years Increase PGC1A promoter methylation in whole blood children measured annually from
5–7 years (n = 40)
No, but measures at
multiple time points
[54]
Maternal exposure or phenotype and epigenetic marks in offspring
Prenatal famine 181 DMRs in adult whole blood (n = 48), including in CDH23, SMAD7, INSR, CPT1A, KLF13, RFTN1
(validated in n = 120)
Yes, technical and 2nd
cohort
[68]
Variation methyl donor intake Changes in mean methylation across BOLA3, LOC654433, EXD3, ZFYVE28, RBM46, and ZNF678 in
blood leukocytes (n = 126) and hair follicles (n = 82) of 2- to 8-month infants
No validation performed [69]
Periconceptional BMI Decreased mean methylation across BOLA3, LOC654433, EXD3, ZFYVE28, RBM46, and ZNF678 in
blood leukocytes (n = 126) and hair follicles (n = 82) of 2- to 8-month infants
No validation performed [69]
Gestational weight gain early pregnancy Increased methylation 4 CpGs in MMP7, KCNK4, TRPM5, and NFKB1 in newborn cord blood




Preconceptional BMI Differential methylation in ZCCHC10 in newborn cord blood (n = 308), other less significant
sites were found in WNT16, ACPL2, C18orf8, ANGPTL2, SAPCD2, and ADCY3
No [73]
Gestational Diabetes 42 CpGs in newborn cord blood (n = 136). ~1/3 of CpGs overlapped with sites that were
associated with maternal glucose levels (n = 36) or micronutrient supplementation (n = 59)
in 2 other child cohorts
Yes, technical and 2 other
cohorts
[70]
Gestational Diabetes No differentially methylated sites (after FDR correction) in cord blood and placenta (n = 44)
but enrichment of sites in genes metabolic disease pathway
No [72]
Intervention
Weight loss surgery Change in methylation at 3601 CpGs (195 DMRs) in subcutaneous adipose tissue and 15 CpGs
in omental adipose tissue (n = 15), some DMRs overlapping known obesity and T2DM loci
Yes, technical [64]
Weight loss surgery 227 DMRs, methylation in these regions also changed with high-fat feeding in mice No, only in mice [43]
Weight loss surgery in liver disease Before surgery 467 differentially methylated CpGs between control (n = 18), healthy obese
(n = 18), steatosis (n = 12), and NASH (n = 15) liver samples. After surgery changes in
methylation at 113 CpGs, disease-associated methylation was reversible at the HOXB1,
PRKCZ, SLC38A10, and SECTM1 loci
No, but for baseline
technical and 2nd cohort
[79]
Weight loss Methylation profiles of RYR1, TUBA3C and BDNF in PBMCs of successful weight loss
maintainers (n = 16) more closely resembled lean (n = 16) than obese subjects (n = 16)
No [77]
Endurance and strength exercise Changes in DNA methylation in skeletal muscle of obese T2DM subjects (n = 17) after
16 weeks, most pronounced with endurance exercise
No [83]
High-fat diet (5 days) PPARGC1A DNA methylation across 4 CpGs increased in subcutaneous adipose tissue of
lean adults born with low birth weight (n = 19) but not in controls (n = 26)
No [76]
BMI body mass index, DMR differentially methylated region, GDM gestational diabetes mellitus, GWAS genome-wide association study, NASH non-alcoholic
steatohepatitis, PBMC peripheral blood mononuclear cell, T2DM type 2 diabetes mellitus, TG triglycerides, WC waist circumference, WHR waist-hip ratio
aIf not otherwise stated the number of subjects includes the total number in discovery and validation sets
bValidation refers to validation of at least some epigenetic marks identified in the primary study cohort. This can be either technical validation, using another method for the measurement of epigenetic marks, or
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an enhancer element upstream of ADCY3 [8]. Other
studies have also identified overlaps between known
obesity and T2DM risk loci and DMRs associated with
obesity and T2DM [43, 48, 62]. Methylation of a num-
ber of such DMRs was also modulated by high-fat
feeding in mice [43] and weight loss in humans [64].
These results identify an intriguing link between gen-
etic variations linked with disease susceptibility and
their association with regions of the genome that undergo
epigenetic modifications in response to nutritional chal-
lenges, implying a causal relationship. The close connec-
tion between genetic and epigenetic variation may signify
their essential roles in generating individual variation
[65, 66]. However, while these findings suggest that DNA
methylation may be a mediator of genetic effects, it is
also important to consider that both genetic and epi-
genetic processes could act independently on the same
genes. Twin studies [8, 63, 67] can provide important
insights and indicate that inter-individual differences in
levels of DNA methylation arise predominantly from
non-shared environment and stochastic influences, min-
imally from shared environmental effects, but also with a
significant impact of genetic variation.
The impact of the prenatal and postnatal environment on
the epigenome
Prenatal environment Two recently published studies
made use of human populations that experienced “nat-
ural” variations in nutrient supply to study the impact of
maternal nutrition before or during pregnancy on DNA
methylation in the offspring [68, 69]. The first study
used a Gambian mother-child cohort to show that both
seasonal variations in maternal methyl donor intake dur-
ing pregnancy and maternal pre-pregnancy BMI were
associated with altered methylation in the infants [69].
The second study utilized adult offspring from the
Dutch Hunger Winter cohort to investigate the effect of
prenatal exposure to an acute period of severe maternal
undernutrition on DNA methylation of genes involved
in growth and metabolism in adulthood [68]. The results
highlighted the importance of the timing of the exposure
in its impact on the epigenome, since significant epigen-
etic effects were only identified in individuals exposed to
famine during early gestation. Importantly, the epigen-
etic changes occurred in conjunction with increased
BMI; however, it was not possible to establish in this
study whether these changes were present earlier in life
or a consequence of the higher BMI.
Other recent studies have provided evidence that pre-
natal overnutrition and an obese or diabetic maternal
environment are also associated with DNA methylation
changes in genes related to embryonic development,
growth, and metabolic disease in the offspring [70–73].While human data are scarce, there are indications
that paternal obesity can lead to altered methylation of
imprinted genes in the newborn [74], an effect thought
to be mediated via epigenetic changes acquired during
spermatogenesis.Postnatal environment The epigenome is established
de novo during embryonic development, and therefore,
the prenatal environment most likely has the most sig-
nificant impact on the epigenome. However, it is now
clear that changes do occur in the “mature” epigenome
under the influence of a range of conditions, including
aging, exposure to toxins, and dietary alterations. For
example, changes in DNA methylation in numerous
genes in skeletal muscle and PGC1A in adipose tissue
have been demonstrated in response to a high-fat diet
[75, 76]. Interventions to lose body fat mass have also
been associated with changes in DNA methylation. Stud-
ies have reported that the DNA methylation profiles of
adipose tissue [43, 64], peripheral blood mononuclear
cells [77], and muscle tissue [78] in formerly obese
patients become more similar to the profiles of lean sub-
jects following weight loss. Weight loss surgery also par-
tially reversed non-alcoholic fatty liver disease-associated
methylation changes in liver [79] and in another study
led to hypomethylation of multiple obesity candidate
genes, with more pronounced effects in subcutaneous
compared to omental (visceral) fat [64]. Accumulating
evidence suggests that exercise interventions can also
influence DNA methylation. Most of these studies have
been conducted in lean individuals [80–82], but one
exercise study in obese T2DM subjects also demon-
strated changes in DNA methylation, including in genes
involved in fatty acid and glucose transport [83]. Epi-
genetic changes also occur with aging, and recent data
suggest a role of obesity in augmenting them [9, 84, 85].
Obesity accelerated the epigenetic age of liver tissue, but
in contrast to the findings described above, this effect
was not reversible after weight loss [84].
Collectively, the evidence in support of the capacity to
modulate the epigenome in adults suggests that there
may be the potential to intervene in postnatal life to
modulate or reverse adverse epigenetic programming.Effect sizes and differences between tissue types
DNA methylation changes associated with obesity or
induced by diet or lifestyle interventions and weight loss
are generally modest (<15 %), although this varies
depending on the phenotype and tissue studied. For in-
stance, changes greater than 20 % have been reported in
adipose tissue after weight loss [64] and associations be-
tween HIF3A methylation and BMI in adipose tissue
were more pronounced than in blood [52].
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changes has been questioned. However, in tissues con-
sisting of a mixture of cell types, a small change in DNA
methylation may actually reflect a significant change in a
specific cell fraction. Integration of epigenome data with
transcriptome and other epigenetic data, such as histone
modifications, is important, since small DNA methyla-
tion changes might reflect larger changes in chromatin
structure and could be associated with broader changes
in gene expression. The genomic context should also be
considered; small changes within a regulatory element
such as a promotor, enhancer, or insulator may have
functional significance. In this regard, DMRs for obesity,
as well as regions affected by prenatal famine exposure
and meQTL for metabolic trait loci have been observed
to overlap enhancer elements [8, 43, 68]. There is evi-
dence that DNA methylation in famine-associated regions
could indeed affect enhancer activity [68], supporting a
role of nutrition-induced methylation changes in gene
regulation.
A major limitation in many human studies is that
epigenetic marks are often assessed in peripheral blood,
rather than in metabolically relevant tissues (Fig. 2). The
heterogeneity of blood is an issue, since different cell
populations have distinct epigenetic signatures, but algo-
rithms have been developed to estimate the cellular
composition to overcome this problem [86]. Perhaps
more importantly, epigenetic marks in blood cells may
not necessarily report the status of the tissues of primary
interest. Despite this, recent studies have provided clear
evidence of a relationship between epigenetic marks in
blood cells and BMI. In the case of HIF3A for which
the level of methylation (beta-value) in the study
population ranged from 0.14–0.52, a 10 % increase in
methylation was associated with a BMI increase of 7.8 %Fig. 2 Overview of human tissues used for studies into the role of epigene
epigenome-wide association studies (EWAS) and pre- and postnatal interve[52]. Likewise, a 10 % difference in PGC1A methylation
may predict up to 12 % difference in fat mass [54].
Conclusions
The study of the role of epigenetics in obesity and meta-
bolic disease has expanded rapidly in recent years, and
evidence is accumulating of a link between epigenetic
modifications and metabolic health outcomes in humans.
Potential epigenetic biomarkers associated with obesity
and metabolic health have also emerged from recent
studies. The validation of epigenetic marks in multiple
cohorts, the fact that several marks are found in genes
with a plausible function in obesity and T2DM develop-
ment, as well as the overlap of epigenetic marks with
known obesity and T2DM genetic loci strengthens the
evidence that these associations are real. Causality has
so far been difficult to establish; however, regardless
of whether the associations are causal, the identified
epigenetic marks may still be relevant as biomarkers
for obesity and metabolic disease risk.
Effect sizes in easily accessible tissues such as blood
are small but do seem reproducible despite variation in
ethnicity, tissue type, and analysis methods [51]. Also,
even small DNA methylation changes may have bio-
logical significance. An integrative “omics” approach will
be crucial in further unraveling the complex interactions
between the epigenome, transcriptome, genome, and
metabolic health. Longitudinal studies, ideally spanning
multiple generations, are essential to establishing causal
relationships. We can expect more such studies in the
future, but this will take time.
While animal studies continue to demonstrate an
effect of early life nutritional exposure on the epigenome
and metabolic health of the offspring, human data are
still limited. However, recent studies have provided cleartics in obesity. For each tissue, studies are grouped by study type;
ntions. Numbers represent the reference number
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specific periods of prenatal development is associated
with methylation changes in the offspring and therefore
have the potential to influence adult phenotype. Animal
studies will be important to verify human findings in a
more controlled setting, help determine whether the
identified methylation changes have any impact on meta-
bolic health, and unravel the mechanisms underlying this
intergenerational/transgenerational epigenetic regulation.
The identification of causal mechanisms underlying me-
tabolic memory responses, the mode of transmission of
the phenotypic effects into successive generations, the
degree of impact and stability of the transmitted trait,
and the identification of an overarching and unifying
evolutionary context also remain important questions to
be addressed. The latter is often encapsulated by the pre-
dictive adaptive response hypothesis, i.e., a response to a
future anticipated environment that increases fitness of
the population. However, this hypothesis has increasingly
been questioned as there is limited evidence for increased
fitness later in life [87].
In summary, outcomes are promising, as the epigen-
etic changes are linked with adult metabolic health and
they act as a mediator between altered prenatal nutrition
and subsequent increased risk of poor metabolic health
outcomes. New epigenetic marks have been identified
that are associated with measures of metabolic health.
Integration of different layers of genomic information
has added further support to causal relationships, and
there have been further studies showing effects of pre-
and postnatal environment on the epigenome and health.
While many important questions remain, recent meth-
odological advances have enabled the types of large-scale
population-based studies that will be required to address
the knowledge gaps. The next decade promises to be a
period of major activity in this important research area.
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